Professor, Medicine, UCSF School of Medicine
Hematology
Dr. Marc A. Shuman, MD
|
|
Give Review
Marc Shuman practices Hematology. He went to medical school at Jefferson Medical College. He received 1 awards: "Elected to Membership". Doctor Marc A. Shuman, MD is a published doctor. He published 69 publications, including: 'Death-defying yeast identify novel apoptosis genes.' Marc A. Shuman accepts Medicare.
Publications
- EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.
- WITHDRAWN: Enhanced Detection and Phenotypic and Karyotypic in Situ Characterization of Circulating Tumor Cells.
- Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.
- Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
- Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating Cell volume dynamics.
- Immunochemotherapy with Intensive Consolidation for Primary Central Nervous System Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI.
- Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensors.
- Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.
- Differential gene expression in central nervous system lymphoma.
- Protein biomarker identification in the CSF of patients with CNS lymphoma.
- Quinine/quinidine-induced thrombocytopenia: a great imitator.
- Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment.
- Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal Cells.
- Hemorrhage and VEGF expression in a case of primary CNS lymphoma.
- Upregulation of Cyclin B1 by miRNA and its implications in cancer.
- The unfolded protein response during prostate cancer development.
- Symposium on androgen action in prostate cancer.
- Gene expression and angiotropism in primary CNS lymphoma.
- The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs.
- Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
- Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial canc...
- Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer an...
- Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.
- Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.
- The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue.
- Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
- Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor Cells.
- Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model.
- Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
- Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate.
- Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
- Prevention of metastasis by inhibition of the urokinase receptor.
- Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
- Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves.
- Characterization of a human Kaposi's sarcoma Cell line that induces angiogenic tumors in animals.
- Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer Cells.
- Endocytosis of fibrinogen into hamster megakaryocyte alpha granules is dependent on a dimeric gamma A configuration.
- Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa)
- Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor c...
- Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia.
- Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer.
- Death-defying yeast identify novel apoptosis genes.
- A nonradioactive assay for type IV collagen degradation.
- Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs.
- Effects of Cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
- Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
- Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa.
- Platelet glycoprotein IIb. Chromosomal localization and tissue expression.
- Immunogold-surface replica study of ADP-induced ligand binding and fibrinogen receptor clustering in human platelets.
- Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules.
- Tissue plasminogen activator in cultured human trabecular meshwork Cells. Predominance of enzyme over plasminogen activator inhibitor.
- In vivo defibrination results in markedly decreased amounts of fibrinogen in rat megakaryocytes and platelets.
- The origin of platelet alpha-granule proteins.
- Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules.
- Decreased prostate cancer Cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor.
- Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain.
- Characterization of the effects of cultured vascular Cells on the activation of blood coagulation.
- The number of receptors for factor VII correlates with the ability of cultured Cells to initiate coagulation.
- Prophylactic heparin in APL.
- The binding of human and bovine thrombin to human platelets.
- Characteristics of the membrane defect in the hereditary stomatocytosis syndrome.
- Cloning of glycoprotein IIIa cDNA from human erythroleukemia Cells and localization of the gene to chromosome 17.
- The transglutaminase in vascular Cells and tissues could provide an alternate pathway for fibrin stabilization.
- Immunohistochemical localization of membrane and alpha-granule proteins in human megakaryocytes: application to plastic-embedded bone marrow biopsy specimens.
- Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa.
- Combined idiopathic Neutropenia and thrombocytopenia: evidence for an immune basis for the syndrome.
- Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation.
- A simple method for the isolation and culture of epithelial and stromal Cells from benign and neoplastic prostates.
Schools
Jefferson Med CollThos Jefferson Univ
Pennsylvania Hospital
Hospital Of The University Of Pennsylvania
Barnes Jewish Hospital
Conditions Treated
- Anemia
- Deep Vein Thrombosis (DVT)
- Neutropenia
- Sickle Cell Disease
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Elected to Membership
Education
-
Washington University - Barnes-Jewish Hospital -
University of Pennsylvania Health System -
Pennsylvania Hospital - University of Pennsylvania Health System -
Jefferson Medical College
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992745095 |
| Last Name Of The Provider | SHUMAN |
| First Name Of The Provider | MARC |
| View All |
Similar Doctors
|
|
Dr. Rebecca Olin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Cohen, MD |
|
|
Dr. Timothy R. Hamill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara G. Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela N. Munster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen M. Hege, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Y. Oh, MD |
|
|
Dr. Elizabeth I. Read, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter H. Sayre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neelima Vidula, MD |
|
|
Dr. Nancy K. Valente, MD |